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In This IssueIn Review: Targeting Bacterial Central Metabolism
PAGE 1423
Antibacterial drug resistance is front-page news these days and highlights the current stagnation in developing new antibi-
otics and the ability of pathogens to acquire resistance. Murima et al. discuss how to target bacterial central metabolism,
as this approach might be a winning strategy to yield new antibiotics.In Review: c-Jun N-Terminal Kinase Inhibitors as
Anticancer Agents
PAGE 1433
Why is the discovery of anticancer therapy targeting JNKs a challenge? Messoussi
et al. review the role of JNKs in tumor progression and use structural and medicinal
chemistry-based analysis to argue that designing ATP-competitive isoform-selective
inhibitors of JNKs is a challenging but achievable goal.
Teasing out Allergic Response
PAGE 1445
Allergens contain multiple molecules capable of eliciting an allergic response. Handlogten et al. use two well-defined
tetravalent allergens to model allergen mixtures and investigate their effect on severity of the response. The results reveal
a complex relationship between activation and suppression of allergy.
Michael Cyclization in Iridoid Biosynthesis
PAGE 1452
Lindner et al. report that enzymatic assay of two substrate analogs, along with clues from the product profile of the native
substrate, strongly suggest that the iridoid synthase enzyme utilizes a Michael reaction to achieve cyclization.
From Quorum Sensing to Cytotoxic and Proinflammatory Activities
PAGE 1457
AgrD is the precursor for the autoinducing peptide in a quorum-sensing system regulating virulence of Staphylococcus
aureus. Gonzalez et al. use molecular networking to identify formylated and nonformylated peptide variants derived from
the AgrD leader domain and reveal unexpected cytotoxic and proinflammatory activities.
EZH2 Inhibitor Efficacy in Non-Hodgkin Lymphoma
PAGE 1463
Targeting EZH2 could be a valid strategy for the treatment of lymphoma patients with EZH2mutations. Bradley et al. describe
the discovery of potent, selective EZH2 inhibitors that cause broad cell killing across various non-Hodgkin lymphoma
subtypes and achieve efficacy in a lymphoma xenograft model.TargetingDrug-ResistantProstateCancerCells
PAGE 1476
The androgen receptor (AR) is an intensively studied therapeutic target impli-
cated in the development and progression of prostate cancer (PCa). Munuganti
et al report a small molecule that inhibits AR activity in a unique manner and is
very potent in in vitro assays and PCa xenograft models.No Beneficial Effect for AMP Deaminase
Inhibition
PAGE 1486
AMP deaminase (AMPD) was proposed to be a potential antidiabetes
drug target given its role in regulating AMPK via AMP elevation. Admyre et al.profile potent AMPD inhibitors and Ampd1-deficient mice and report that neither pharmacologic nor genetic deletion of
AMPD function delivered any beneficial metabolic effects.
How AMP Deaminase Inhibition Affect Skeletal Muscles
PAGE 1497
Plaideau et al. show that AMP-deaminase (AMPD) inhibition leads to a substantial enhancement of contraction-induced
AMP accumulation in skeletal muscles. However, this does not always lead to the expected potentiation of AMPK activation,
suggesting control by factors other than nucleotides.Chemistry & Biology 21, November 20, 2014 ª2014 Elsevier Ltd All rights reserved ix
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PAGE 1511
Holder and Hartig present results of a systematic analysis of the influence of quadruplex sequences in bacterial gene-
regulatory regions. The authors observe drastic effects of four-stranded nucleic acid sequences on gene expression within
designed and natural genetic contexts in a strand- and position-dependent manner.K8L9 and Melittin Enter Cancer Cells via Receptor Endocytosis
PAGE 1522
Kohno et al. show that membrane-lytic peptides K8L9 and melittin not only disrupt the cell membrane but can also enter
cancer cells via receptor endocytosis following subcytotoxic treatment and subsequently affect lysosomal compartments.
Hsc70 participates in the cell entry and cellular traffic process of these peptides.GAPDH Moonlighting Function Has a Role in Tubulin Regulation
PAGE 1533
Many housekeeping proteins, like GAPDH, carry out moonlighting functions. Jung et al. use a unique chemical probe that
targets moonlighting by GAPDH, which revealed a role for GAPDH in tubulin regulation and produced potent anticancer
effects. Thus, targeting protein moonlighting can be a novel approach for drug discovery.Intracellular Calcium Levels Modulate Allosteric
Interactions of GPCR Heteromers
PAGE 1546
Navarro et al. demonstrate that intracellular calcium levels determine which neuronal
calcium-binding protein interacts and selectively modulates the function of the adeno-
sine A2A-dopamine D2 receptor heteromer, a very important pharmacological target
in Parkinson’s disease.Farnesol Is Involved in Biofilm Production
PAGE 1557
Feng et al. show that the protein YisP, essential for biofilm formation in B. subtilis, is a
phosphatase that unexpectedly produces the sesquiterpene alcohol farnesol rather
than the expected C30 polyisoprenoids. They also show that YisP-dependent farnesol
production triggers biofilm formation.Activation of UPRReduces Extracellular Aggregation
of Amyloidogenic Serum Proteins
PAGE 1564
Systemic amyloidoses result from the secretion and proteotoxic aggregation of destabilized, amyloidogenic serum proteins
such as transthyretin. Chen et al. show that activation of the unfolded protein response transcription factor ATF6 reduces the
secretion and extracellular aggregation of disease-associated transthyretin variants.x Chemistry & Biology 21, November 2Metabolite Map of the Brain
PAGE 1575
Ivanisevic et al. develop an untargeted metabolomics method for the simultaneous
measurement of a broad range of metabolites from brain tissue. Brain tissue region-
specific analysis offers unique information about localized metabolic activity and can
provide insights into complexity of neural function.PMI: A Pharmacological Regulator of Mitophagy
PAGE 1585
East et al. develop a pharmacological tool, PMI, to investigate the molecular mechanisms of mitophagy. PMI circumvents
the toxicity and some nonspecific effects associated with the abrupt dissipation of mitochondrial membrane potential by
ionophores that are routinely used to induce mitophagy.0, 2014 ª2014 Elsevier Ltd All rights reserved
